(PharmaNewsWire.Com, September 11, 2017 ) According to the report Asia Pacific Surgical Sealants and Adhesives Market, published by Market Data Forecast, the Market size was almost USD 360 million in 2016. It is expected to grow at a CAGR of 9.8 % to reach USD 570 million by 2021. It is the fastest growing market capturing a 19% of the global market share.
In modern surgical procedures sealants and adhesives have become useful accompaniments as they have evolved over the years. Their efficacy, usability in repairing injured tissues, safety and support for wounds obtained during surgery are the causes for their widescale adoption.
Rising concerns to reduce surgical wounds along with growing demand for surgical services are the primary causes for market growth. Approximately 235 million major surgeries are carried out globally per year as per the WHO estimates which augurs well for the market. It is because surgical procedures are usually accompanied by risk of wound infection, tissue damage or excessive bleeding.The limiting factors for market growth are high costs, cumbersome regulatory procedures and stringent rules of compliance.
The Asia Pacific Surgical Sealants and Adhesives market can be categorized into three categories: by product, by indication and by application. On the basis of product, Asia Pacific Surgical Sealants and Adhesives market is classified into Natural/Biological Sealants and Adhesives and Synthetic and Semi-Synthetic Sealants and Adhesives. Natural/Biological Sealants and Adhesives is further segmented into type and origin. By type it is categorized into Polypeptide/Protein-based Sealants and Adhesives (Fibrin-based Adhesives, Gelatine-based Adhesives, Collagen-based Adhesives and Albumin-based Adhesives) and Polysaccharide-based Sealants and Adhesives (Polysaccharide-based Sealants and Adhesives and Other Polysaccharide-based Adhesives). By Origin it sub-segmented into Human Blood-based and Animal-based. Further, Synthetic and Semi-Synthetic Sealants and Adhesives has been categorized into Cyanoacrylates, Polyethylene glycol Hydrogels, Urethane-based Adhesives and Other Synthetic Adhesives. In the polypeptide sealants and adhesives category, the fibrin-based adhesives commanded the largest market share because of the wide range of applications of these sealants in surgical areas for example, cardiac, spleen surgeries, liver, colonic anastomosis, and seroma prevention after soft tissue dissections.
Furthermore, the gelatine-based adhesives category is estimated to grow at the highest CAGR during the aforementioned forecast period because of their tensile strength, high elasticity and high-adhesive. Moreover, on the basis of indication, the market is segmented into Surgical Haemostasis, Tissue Sealing and Tissue Engineering. In addition, on the basis of application the market can be categorized into Central Nervous System (CNS) Surgeries, General Surgeries, Cardiovascular Surgeries, Orthopaedic Surgeries, Cosmetic Surgeries, Urological Surgeries, Pulmonary Surgeries, Ophthalmic Surgeries and Other Applications.
By geography, the Asia Pacific Surgical Sealants and Adhesives market has been categorized into India, China, Korea, Japan and other countries. Presently, Asia Pacific has the highest CAGR. Creation of a sustainable health system because of the ongoing transformation of healthcare delivery systems into advanced value-based healthcare practices is the primary cause attributable to the observable trend mentioned above. This makes better facilities available at cheaper rates and promote the use of novel techniques in surgeries and other healthcare practices. Secondary factors include increasing medical tourism, growing per capita income, the presence of less stringent regulations and rise in investment by major players in this region.
CryoLife, Inc. (U.S.), Johnson & Johnson (Ethicon, Inc., Baxter International, Inc. (U.S.), and C.R. Bard, Inc. (U.S.) held the key share of the surgical sealants and adhesives market and are likely continue to dominate the market between 2016 and 2021. Some of the primary players operating in this market are Cohera Medical, Inc. (U.S.), Ocular Therapuetix, Inc. (U.S.), Vivostat A/S (Denmark), and Sealantis Ltd. (Israel), Medtronic plc (U.S.), Sanofi Group (France), B. Braun Melsungen AG (Germany).
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
